These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20176799)

  • 1. Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction.
    Vuilleumier N; Rossier MF; Pagano S; Python M; Charbonney E; Nkoulou R; James R; Reber G; Mach F; Roux-Lombard P
    Eur Heart J; 2010 Apr; 31(7):815-23. PubMed ID: 20176799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy.
    Vuilleumier N; Montecucco F; Spinella G; Pagano S; Bertolotto M; Pane B; Pende A; Galan K; Roux-Lombard P; Combescure C; Dallegri F; Mach F; Palombo D
    Thromb Haemost; 2013 Apr; 109(4):706-15. PubMed ID: 23364307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
    Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
    Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
    Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
    Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD14 as a Mediator of the Mineralocorticoid Receptor-Dependent Anti-apolipoprotein A-1 IgG Chronotropic Effect on Cardiomyocytes.
    Mannic T; Satta N; Pagano S; Python M; Virzi J; Montecucco F; Frias MA; James RW; Maturana AD; Rossier MF; Vuilleumier N
    Endocrinology; 2015 Dec; 156(12):4707-19. PubMed ID: 26393305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic value of symptoms and signs of advanced heart failure and low left ventricle ejection fraction in patients after myocardial infarction with chronic heart failure].
    Kuch M; Janiszewski M; Janiszewski M; Braksator W; Mamcarz A; Sadkowska K; Kuch J; Dłuzniewski M
    Pol Merkur Lekarski; 2006 Mar; 20(117):285-8. PubMed ID: 16780256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex.
    Pagano S; Satta N; Werling D; Offord V; de Moerloose P; Charbonney E; Hochstrasser D; Roux-Lombard P; Vuilleumier N
    J Intern Med; 2012 Oct; 272(4):344-57. PubMed ID: 22329401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis.
    Vuilleumier N; Bas S; Pagano S; Montecucco F; Guerne PA; Finckh A; Lovis C; Mach F; Hochstrasser D; Roux-Lombard P; Gabay C
    Arthritis Rheum; 2010 Sep; 62(9):2640-50. PubMed ID: 20506304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability.
    Montecucco F; Vuilleumier N; Pagano S; Lenglet S; Bertolotto M; Braunersreuther V; Pelli G; Kovari E; Pane B; Spinella G; Pende A; Palombo D; Dallegri F; Mach F; Roux-Lombard P
    Eur Heart J; 2011 Feb; 32(4):412-21. PubMed ID: 21224292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarction.
    Rubini Gimenez M; Pagano S; Virzi J; Montecucco F; Twerenbold R; Reichlin T; Wildi K; Grueter D; Jaeger C; Haaf P; Vuilleumier N; Mueller C
    Eur J Clin Invest; 2015 Apr; 45(4):369-79. PubMed ID: 25627775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The predictive value for major arrhythmic events of ventricular arrhythmias, particularly nonsustained ventricular tachycardias, in the subacute phase of a fibrinolyzed infarct. An analysis of GISSI-2 data. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Giani P; Avanzini F; Bagliani G; Galati A; Pucci P; Santoro E
    G Ital Cardiol; 1995 Jan; 25(1):77-87. PubMed ID: 7642014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between red blood cell distribution width and outcomes at six months in patients with acute coronary syndromes.
    Nabais S; Losa N; Gaspar A; Rocha S; Costa J; Azevedo P; Basto L; Pereira MA; Correia A
    Rev Port Cardiol; 2009 Sep; 28(9):905-24. PubMed ID: 19998803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure.
    Iwaoka M; Obata JE; Abe M; Nakamura T; Kitta Y; Kodama Y; Kawabata K; Takano H; Fujioka D; Saito Y; Kobayashi T; Hasebe H; Kugiyama K
    J Card Fail; 2007 May; 13(4):247-53. PubMed ID: 17517342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traditional and nonlinear heart rate variability are each independently associated with mortality after myocardial infarction.
    Stein PK; Domitrovich PP; Huikuri HV; Kleiger RE;
    J Cardiovasc Electrophysiol; 2005 Jan; 16(1):13-20. PubMed ID: 15673380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of aldosterone in patients with acute coronary syndrome: short and medium term follow-up.
    Mignano A; Pitruzzella V; Arnone G; Arnone MT; Rotolo A; Assennato P; Novo G; Corrado E; Novo S
    J Cardiovasc Med (Hagerstown); 2014 Jan; 15(1):27-32. PubMed ID: 23867910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials.
    Kang S; Yang Y; Li CJ; Gao R
    Clin Ther; 2007 Nov; 29(11):2406-18. PubMed ID: 18158081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction.
    Keller PF; Pagano S; Roux-Lombard P; Sigaud P; Rutschmann OT; Mach F; Hochstrasser D; Vuilleumier N
    J Intern Med; 2012 May; 271(5):451-62. PubMed ID: 22061093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome.
    Leung S; Gallup D; Mahaffey KW; Cohen M; Antman EM; Goodman SG; Harrington RA; Langer A; Aylward P; Ferguson JJ; Califf RM;
    Am Heart J; 2008 Jul; 156(1):177-84. PubMed ID: 18585514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry).
    Lee JH; Park HS; Chae SC; Cho Y; Yang DH; Jeong MH; Kim YJ; Kim KS; Hur SH; Seong IW; Hong TJ; Cho MC; Kim CJ; Jun JE; Park WH;
    Am J Cardiol; 2009 Jul; 104(2):182-9. PubMed ID: 19576343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
    Latini R; Maggioni AP; Peri G; Gonzini L; Lucci D; Mocarelli P; Vago L; Pasqualini F; Signorini S; Soldateschi D; Tarli L; Schweiger C; Fresco C; Cecere R; Tognoni G; Mantovani A;
    Circulation; 2004 Oct; 110(16):2349-54. PubMed ID: 15477419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.